• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-28-5p通过抑制N4BP1促进卵巢癌的发展和进展。

miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.

作者信息

Xu Juan, Jiang Nan, Shi Haijuan, Zhao Shanshan, Yao Shuzhong, Shen Huimin

机构信息

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.

出版信息

Int J Oncol. 2017 Apr;50(4):1383-1391. doi: 10.3892/ijo.2017.3915. Epub 2017 Mar 16.

DOI:10.3892/ijo.2017.3915
PMID:28350078
Abstract

MicroRNAs (miRNAs) play important roles in transcriptional regulation by targeting the 3'-UTR of target genes which participate in various biological processes. We aimed to investigate the potential role of miR-28-5p in the process of ovarian cancer development through regulating N4BP1. We found that the mRNA expression level of miR-28-5p was significantly increased in ovarian cancer tissues in comparison with adjacent ovarian tissues by qRT-PCR (P<0.0001). We established that miR‑28‑5p promoted the progression of ovarian cancer cell proliferation using colony forming assay and MTT assay. Wound healing assay and the migration and invasion assay showed that miR‑28‑5p accelerated the migration and invasion abilities of ovarian cancer cells. Simultaneously, we showed that miR‑28‑5p promoted ovarian cancer cell cycle, and inhibited apoptosis by flow cytometry in vitro. Furthermore, the results showed that miR‑28‑5p promoted the growth of ovarian tumor by tumor formation assay in vivo. The results of western blot analysis indicated that miR‑28‑5p promoted the protein expression level of F-actin. Western blot analysis also demonstrated that miR‑28‑5p promoted the progress of epithelial-mesenchymal transition (EMT) in ovarian carcinoma cells. In addition, we found that miR‑28‑5p downregulated N4BP1 mRNA and protein expression by qRT-PCR and western blot analysis in human ovarian cancer. Therefore, our study indicated that miR‑28‑5p promoted the progression of ovarian cancer cell cycle, proliferation, migration and invasion, inhibited apoptosis, and induced the process of EMT through inhibition of N4BP1 in vitro. Moreover, miR‑28‑5p promoted the growth of ovarian tumor in vivo.

摘要

微小RNA(miRNA)通过靶向参与各种生物学过程的靶基因的3'-非翻译区(3'-UTR)在转录调控中发挥重要作用。我们旨在通过调节N4BP1来研究miR-28-5p在卵巢癌发生过程中的潜在作用。通过qRT-PCR我们发现,与相邻卵巢组织相比,miR-28-5p在卵巢癌组织中的mRNA表达水平显著升高(P<0.0001)。我们通过集落形成试验和MTT试验确定miR-28-5p促进卵巢癌细胞增殖进程。伤口愈合试验以及迁移和侵袭试验表明,miR-28-5p加速了卵巢癌细胞的迁移和侵袭能力。同时,我们通过体外流式细胞术表明miR-28-5p促进卵巢癌细胞周期进程并抑制细胞凋亡。此外,体内肿瘤形成试验结果表明miR-28-5p促进卵巢肿瘤生长。蛋白质印迹分析结果表明,miR-28-5p促进F-肌动蛋白的蛋白表达水平。蛋白质印迹分析还证明,miR-28-5p促进卵巢癌细胞上皮-间质转化(EMT)进程。此外,通过qRT-PCR和蛋白质印迹分析我们发现,在人卵巢癌中miR-28-5p下调N4BP1的mRNA和蛋白表达。因此,我们的研究表明,miR-28-5p在体外通过抑制N4BP1促进卵巢癌细胞周期进程、增殖、迁移和侵袭,抑制细胞凋亡,并诱导EMT进程。此外,miR-28-5p在体内促进卵巢肿瘤生长。

相似文献

1
miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.微小RNA-28-5p通过抑制N4BP1促进卵巢癌的发展和进展。
Int J Oncol. 2017 Apr;50(4):1383-1391. doi: 10.3892/ijo.2017.3915. Epub 2017 Mar 16.
2
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向,增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
3
Extracellular vesicles derived from lung cancer cells promote the progression of lung cancer by delivering miR-151a-5p.源自肺癌细胞的细胞外囊泡通过传递miR-151a-5p促进肺癌进展。
Exp Cell Res. 2023 Apr 1;425(1):113526. doi: 10.1016/j.yexcr.2023.113526. Epub 2023 Feb 23.
4
miR‑28‑5p inhibits the migration of breast cancer by regulating WSB2.miR-28-5p 通过调控 WSB2 抑制乳腺癌的迁移。
Int J Mol Med. 2020 Oct;46(4):1562-1570. doi: 10.3892/ijmm.2020.4685. Epub 2020 Jul 27.
5
Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.长链非编码RNA NORAD通过miR-30a-5p/RAB11A/WNT/β-连环蛋白通路促进前列腺癌的增殖、侵袭和上皮-间质转化进程。
Cancer Cell Int. 2020 Nov 27;20(1):571. doi: 10.1186/s12935-020-01665-2.
6
MiR-193a-5p suppresses cell proliferation and induces cell apoptosis by regulating HOXA7 in human ovarian cancer.miR-193a-5p 通过调控 HOXA7 抑制人卵巢癌细胞增殖并诱导细胞凋亡。
Neoplasma. 2020 Jul;67(4):825-833. doi: 10.4149/neo_2020_190730N687. Epub 2020 Apr 16.
7
Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway.Circ_0015756通过调控miR-942-5p/CUL4B通路促进卵巢癌进展。
Cancer Cell Int. 2020 Nov 27;20(1):572. doi: 10.1186/s12935-020-01666-1.
8
LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.长链非编码 RNA ADPGK-AS1 通过激活 ZEB1 介导的上皮-间充质转化促进胰腺癌进展。
Cancer Biol Ther. 2018 Jul 3;19(7):573-583. doi: 10.1080/15384047.2018.1423912. Epub 2018 Apr 19.
9
MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.miR-140-5p 和 miR-92a-3p 通过靶向 FRS2 抑制肾母细胞瘤细胞增殖、迁移和侵袭并促进凋亡。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):97-108. doi: 10.26355/eurrev_202001_19899.
10
miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.miR-196a-5p 通过靶向 IκBα 促进结直肠癌转移。
BMC Cancer. 2019 Jan 8;19(1):30. doi: 10.1186/s12885-018-5245-1.

引用本文的文献

1
miR-28: A Tiny Player in Cancer Progression and Other Human Diseases.微小RNA-28:癌症进展及其他人类疾病中的小角色
Biomolecules. 2025 May 24;15(6):757. doi: 10.3390/biom15060757.
2
Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML.外泌体miR-92b-5p通过调节N4BP1增强多柔比星耐药急性髓系白血病中的PTEN单泛素化。
Cancer Drug Resist. 2025 Mar 28;8:16. doi: 10.20517/cdr.2024.140. eCollection 2025.
3
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).
DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
4
Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survival.来自三维卵巢癌体外模型的细胞外囊泡微小RNA及其在癌症总体生存中的意义。
Heliyon. 2025 Jan 23;11(4):e42188. doi: 10.1016/j.heliyon.2025.e42188. eCollection 2025 Feb 28.
5
Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma.人源微小RNA-28-5p对弥漫性大B细胞淋巴瘤阿霉素敏感性的影响
Evid Based Complement Alternat Med. 2022 Jul 13;2022:4290994. doi: 10.1155/2022/4290994. eCollection 2022.
6
inhibits carcinogenesis in colon cancer cells and is necessary for erastin-induced ferroptosis.抑制结肠癌细胞的致癌作用,是埃拉斯汀诱导铁死亡所必需的。
Transl Cancer Res. 2020 Apr;9(4):2931-2940. doi: 10.21037/tcr-20-1809.
7
hsa-MicroRNA-28-5p Inhibits Diffuse Large B-Cell Lymphoma Cell Proliferation by Downregulating 14-3-3 Expression.人源微小RNA-28-5p通过下调14-3-3表达抑制弥漫性大B细胞淋巴瘤细胞增殖。
Evid Based Complement Alternat Med. 2022 Jan 4;2022:4605329. doi: 10.1155/2022/4605329. eCollection 2022.
8
Reduced Levels of miR-28 and miR-200a Act as Predictor Biomarkers of Aggressive Clinicopathological Characteristics in Gastric Cancer Patients.miR-28和miR-200a水平降低可作为胃癌患者侵袭性临床病理特征的预测生物标志物。
Galen Med J. 2019 Jan 25;8:e1329. doi: 10.31661/gmj.v8i0.1329. eCollection 2019.
9
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.癌症中MHC I类分子下调:潜在机制及癌症免疫治疗的潜在靶点
Cancers (Basel). 2020 Jul 2;12(7):1760. doi: 10.3390/cancers12071760.
10
Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer.miR-28-5p 在结肠癌中的临床意义和预后价值。
Dis Markers. 2020 May 20;2020:3159831. doi: 10.1155/2020/3159831. eCollection 2020.